What Are the Challenges in Targeting Immune Evasion?
While immunotherapy has shown promise, it is not effective for all patients. Tumors can develop resistance to immunotherapy by upregulating other inhibitory pathways or by creating a more immunosuppressive microenvironment. Additionally, the heterogeneity of tumors means that a single approach may not be effective for all cancer types or even all patients with the same type of cancer.
